Loading…
Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants
This study reports on 10 frontline healthcare workers, employed during the COVID-19 pandemic and experiencing symptoms of burnout and PTSD, treated with group ketamine-assisted psychotherapy (KAP) in a private outpatient clinic setting. Participants attended 6 sessions once weekly. These included 1...
Saved in:
Published in: | Journal of psychoactive drugs 2024-01, Vol.56 (1), p.1-32 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c370t-f53a81a92e2b79751014106e27266ccb03d01b04fa29def26854ca22ad7fb9823 |
---|---|
cites | cdi_FETCH-LOGICAL-c370t-f53a81a92e2b79751014106e27266ccb03d01b04fa29def26854ca22ad7fb9823 |
container_end_page | 32 |
container_issue | 1 |
container_start_page | 1 |
container_title | Journal of psychoactive drugs |
container_volume | 56 |
creator | Robison, Reid Brendle, Madeline Moore, Claire Cross, Hannah Helm, Lindsay Darling, Shannon Thayer, Stephen Thielking, Paul Shannon, Scott |
description | This study reports on 10 frontline healthcare workers, employed during the COVID-19 pandemic and experiencing symptoms of burnout and PTSD, treated with group ketamine-assisted psychotherapy (KAP) in a private outpatient clinic setting. Participants attended 6 sessions once weekly. These included 1 preparation session, 3 ketamine sessions (2 sublingual, 1 intramuscular), 2 integration sessions. Measures of PTSD (PCL-5), depression (PHQ-9), and anxiety (GAD-7) were administered at baseline and post-treatment. During ketamine sessions, the Emotional Breakthrough Inventory (EBI) and the 30-item Mystical Experience Questionnaire (MEQ-30) were recorded. Participant feedback was gathered 1-month post-treatment. We observed improvements in participants' average PCL-5 (59% reduction), PHQ-9 (58% reduction), and GAD-7 (36% reduction) scores from pre- to post-treatment. At post-treatment, 100% of participants screened negative for PTSD, 90% had minimal/mild depression or clinically significant improvement, and 60% had minimal/mild anxiety or clinically significant improvement. MEQ and EBI scores had large variations among participants at each ketamine session. Ketamine was well tolerated, and no significant adverse events were reported. Participant feedback corroborated findings of improvements observed in mental health symptoms. We found immediate improvements treating 10 frontline healthcare workers experiencing burnout, PTSD, depression, and anxiety using weekly group KAP and integration. |
doi_str_mv | 10.1080/02791072.2023.2186285 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2783493452</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2942021095</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-f53a81a92e2b79751014106e27266ccb03d01b04fa29def26854ca22ad7fb9823</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhi0Eape2PwFkiQuXbO1xEsfclu2nqNRVt4Vj5DhjbUo2DrYD2n_EzyTRbjn0NJfnfWdGDyEfOJtzVrBzBlJxJmEODMQceJFDkb0hM-CZSpSU8i2ZTUwyQcfkfQjPjLEc8vyIHIt8wkHNyN9vGPW26TBZhNCEiDW99m7o6SrszMbFDXrd76h1nl5518V2ROkN6jZujPZIfzj_E32gf5q4ocv777cXCVfJA7Z6qvo6-M4NkequpqvH9cUXuqBLHZCu0TcYqLP00lo0sfmNHYZwvtYW434dZ3SlfWxM0-suhlPyzuo24NlhnpCnq8vH5U1yd399u1zcJUZIFhObCV1wrQChkkpmnPGUsxxBjp8bUzFRM16x1GpQNVrIiyw1GkDX0laqAHFCPu97e-9-DRhiuW2CwbbVHbohlCALkSqRZhP66RX67MaHx-tKUOnohTOVjVS2p4x3IXi0Ze-brfa7krNyUlm-qCwnleVB5Zj7eGgfqi3W_1Mv7sQ_WhOZCw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2942021095</pqid></control><display><type>article</type><title>Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Robison, Reid ; Brendle, Madeline ; Moore, Claire ; Cross, Hannah ; Helm, Lindsay ; Darling, Shannon ; Thayer, Stephen ; Thielking, Paul ; Shannon, Scott</creator><creatorcontrib>Robison, Reid ; Brendle, Madeline ; Moore, Claire ; Cross, Hannah ; Helm, Lindsay ; Darling, Shannon ; Thayer, Stephen ; Thielking, Paul ; Shannon, Scott</creatorcontrib><description>This study reports on 10 frontline healthcare workers, employed during the COVID-19 pandemic and experiencing symptoms of burnout and PTSD, treated with group ketamine-assisted psychotherapy (KAP) in a private outpatient clinic setting. Participants attended 6 sessions once weekly. These included 1 preparation session, 3 ketamine sessions (2 sublingual, 1 intramuscular), 2 integration sessions. Measures of PTSD (PCL-5), depression (PHQ-9), and anxiety (GAD-7) were administered at baseline and post-treatment. During ketamine sessions, the Emotional Breakthrough Inventory (EBI) and the 30-item Mystical Experience Questionnaire (MEQ-30) were recorded. Participant feedback was gathered 1-month post-treatment. We observed improvements in participants' average PCL-5 (59% reduction), PHQ-9 (58% reduction), and GAD-7 (36% reduction) scores from pre- to post-treatment. At post-treatment, 100% of participants screened negative for PTSD, 90% had minimal/mild depression or clinically significant improvement, and 60% had minimal/mild anxiety or clinically significant improvement. MEQ and EBI scores had large variations among participants at each ketamine session. Ketamine was well tolerated, and no significant adverse events were reported. Participant feedback corroborated findings of improvements observed in mental health symptoms. We found immediate improvements treating 10 frontline healthcare workers experiencing burnout, PTSD, depression, and anxiety using weekly group KAP and integration.</description><identifier>ISSN: 0279-1072</identifier><identifier>EISSN: 2159-9777</identifier><identifier>DOI: 10.1080/02791072.2023.2186285</identifier><identifier>PMID: 36862829</identifier><language>eng</language><publisher>United States: Haight Ashbury Publications</publisher><subject>Anxiety ; Burnout ; Clinical significance ; COVID-19 ; Ketamine ; Medical personnel ; Mental depression ; Post traumatic stress disorder ; Psychotherapy</subject><ispartof>Journal of psychoactive drugs, 2024-01, Vol.56 (1), p.1-32</ispartof><rights>2023 Taylor & Francis Group, LLC</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c370t-f53a81a92e2b79751014106e27266ccb03d01b04fa29def26854ca22ad7fb9823</citedby><cites>FETCH-LOGICAL-c370t-f53a81a92e2b79751014106e27266ccb03d01b04fa29def26854ca22ad7fb9823</cites><orcidid>0000-0003-0692-3706</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36862829$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Robison, Reid</creatorcontrib><creatorcontrib>Brendle, Madeline</creatorcontrib><creatorcontrib>Moore, Claire</creatorcontrib><creatorcontrib>Cross, Hannah</creatorcontrib><creatorcontrib>Helm, Lindsay</creatorcontrib><creatorcontrib>Darling, Shannon</creatorcontrib><creatorcontrib>Thayer, Stephen</creatorcontrib><creatorcontrib>Thielking, Paul</creatorcontrib><creatorcontrib>Shannon, Scott</creatorcontrib><title>Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants</title><title>Journal of psychoactive drugs</title><addtitle>J Psychoactive Drugs</addtitle><description>This study reports on 10 frontline healthcare workers, employed during the COVID-19 pandemic and experiencing symptoms of burnout and PTSD, treated with group ketamine-assisted psychotherapy (KAP) in a private outpatient clinic setting. Participants attended 6 sessions once weekly. These included 1 preparation session, 3 ketamine sessions (2 sublingual, 1 intramuscular), 2 integration sessions. Measures of PTSD (PCL-5), depression (PHQ-9), and anxiety (GAD-7) were administered at baseline and post-treatment. During ketamine sessions, the Emotional Breakthrough Inventory (EBI) and the 30-item Mystical Experience Questionnaire (MEQ-30) were recorded. Participant feedback was gathered 1-month post-treatment. We observed improvements in participants' average PCL-5 (59% reduction), PHQ-9 (58% reduction), and GAD-7 (36% reduction) scores from pre- to post-treatment. At post-treatment, 100% of participants screened negative for PTSD, 90% had minimal/mild depression or clinically significant improvement, and 60% had minimal/mild anxiety or clinically significant improvement. MEQ and EBI scores had large variations among participants at each ketamine session. Ketamine was well tolerated, and no significant adverse events were reported. Participant feedback corroborated findings of improvements observed in mental health symptoms. We found immediate improvements treating 10 frontline healthcare workers experiencing burnout, PTSD, depression, and anxiety using weekly group KAP and integration.</description><subject>Anxiety</subject><subject>Burnout</subject><subject>Clinical significance</subject><subject>COVID-19</subject><subject>Ketamine</subject><subject>Medical personnel</subject><subject>Mental depression</subject><subject>Post traumatic stress disorder</subject><subject>Psychotherapy</subject><issn>0279-1072</issn><issn>2159-9777</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpdkU1v1DAQhi0Eape2PwFkiQuXbO1xEsfclu2nqNRVt4Vj5DhjbUo2DrYD2n_EzyTRbjn0NJfnfWdGDyEfOJtzVrBzBlJxJmEODMQceJFDkb0hM-CZSpSU8i2ZTUwyQcfkfQjPjLEc8vyIHIt8wkHNyN9vGPW26TBZhNCEiDW99m7o6SrszMbFDXrd76h1nl5518V2ROkN6jZujPZIfzj_E32gf5q4ocv777cXCVfJA7Z6qvo6-M4NkequpqvH9cUXuqBLHZCu0TcYqLP00lo0sfmNHYZwvtYW434dZ3SlfWxM0-suhlPyzuo24NlhnpCnq8vH5U1yd399u1zcJUZIFhObCV1wrQChkkpmnPGUsxxBjp8bUzFRM16x1GpQNVrIiyw1GkDX0laqAHFCPu97e-9-DRhiuW2CwbbVHbohlCALkSqRZhP66RX67MaHx-tKUOnohTOVjVS2p4x3IXi0Ze-brfa7krNyUlm-qCwnleVB5Zj7eGgfqi3W_1Mv7sQ_WhOZCw</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Robison, Reid</creator><creator>Brendle, Madeline</creator><creator>Moore, Claire</creator><creator>Cross, Hannah</creator><creator>Helm, Lindsay</creator><creator>Darling, Shannon</creator><creator>Thayer, Stephen</creator><creator>Thielking, Paul</creator><creator>Shannon, Scott</creator><general>Haight Ashbury Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K7.</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0692-3706</orcidid></search><sort><creationdate>20240101</creationdate><title>Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants</title><author>Robison, Reid ; Brendle, Madeline ; Moore, Claire ; Cross, Hannah ; Helm, Lindsay ; Darling, Shannon ; Thayer, Stephen ; Thielking, Paul ; Shannon, Scott</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-f53a81a92e2b79751014106e27266ccb03d01b04fa29def26854ca22ad7fb9823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Anxiety</topic><topic>Burnout</topic><topic>Clinical significance</topic><topic>COVID-19</topic><topic>Ketamine</topic><topic>Medical personnel</topic><topic>Mental depression</topic><topic>Post traumatic stress disorder</topic><topic>Psychotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Robison, Reid</creatorcontrib><creatorcontrib>Brendle, Madeline</creatorcontrib><creatorcontrib>Moore, Claire</creatorcontrib><creatorcontrib>Cross, Hannah</creatorcontrib><creatorcontrib>Helm, Lindsay</creatorcontrib><creatorcontrib>Darling, Shannon</creatorcontrib><creatorcontrib>Thayer, Stephen</creatorcontrib><creatorcontrib>Thielking, Paul</creatorcontrib><creatorcontrib>Shannon, Scott</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of psychoactive drugs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Robison, Reid</au><au>Brendle, Madeline</au><au>Moore, Claire</au><au>Cross, Hannah</au><au>Helm, Lindsay</au><au>Darling, Shannon</au><au>Thayer, Stephen</au><au>Thielking, Paul</au><au>Shannon, Scott</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants</atitle><jtitle>Journal of psychoactive drugs</jtitle><addtitle>J Psychoactive Drugs</addtitle><date>2024-01-01</date><risdate>2024</risdate><volume>56</volume><issue>1</issue><spage>1</spage><epage>32</epage><pages>1-32</pages><issn>0279-1072</issn><eissn>2159-9777</eissn><abstract>This study reports on 10 frontline healthcare workers, employed during the COVID-19 pandemic and experiencing symptoms of burnout and PTSD, treated with group ketamine-assisted psychotherapy (KAP) in a private outpatient clinic setting. Participants attended 6 sessions once weekly. These included 1 preparation session, 3 ketamine sessions (2 sublingual, 1 intramuscular), 2 integration sessions. Measures of PTSD (PCL-5), depression (PHQ-9), and anxiety (GAD-7) were administered at baseline and post-treatment. During ketamine sessions, the Emotional Breakthrough Inventory (EBI) and the 30-item Mystical Experience Questionnaire (MEQ-30) were recorded. Participant feedback was gathered 1-month post-treatment. We observed improvements in participants' average PCL-5 (59% reduction), PHQ-9 (58% reduction), and GAD-7 (36% reduction) scores from pre- to post-treatment. At post-treatment, 100% of participants screened negative for PTSD, 90% had minimal/mild depression or clinically significant improvement, and 60% had minimal/mild anxiety or clinically significant improvement. MEQ and EBI scores had large variations among participants at each ketamine session. Ketamine was well tolerated, and no significant adverse events were reported. Participant feedback corroborated findings of improvements observed in mental health symptoms. We found immediate improvements treating 10 frontline healthcare workers experiencing burnout, PTSD, depression, and anxiety using weekly group KAP and integration.</abstract><cop>United States</cop><pub>Haight Ashbury Publications</pub><pmid>36862829</pmid><doi>10.1080/02791072.2023.2186285</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-0692-3706</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0279-1072 |
ispartof | Journal of psychoactive drugs, 2024-01, Vol.56 (1), p.1-32 |
issn | 0279-1072 2159-9777 |
language | eng |
recordid | cdi_proquest_miscellaneous_2783493452 |
source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
subjects | Anxiety Burnout Clinical significance COVID-19 Ketamine Medical personnel Mental depression Post traumatic stress disorder Psychotherapy |
title | Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T13%3A52%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ketamine-Assisted%20Group%20Psychotherapy%20for%20Frontline%20Healthcare%20Workers%20with%20COVID-19-Related%20Burnout%20and%20PTSD:%20A%20Case%20Series%20of%20Effectiveness/Safety%20for%2010%20Participants&rft.jtitle=Journal%20of%20psychoactive%20drugs&rft.au=Robison,%20Reid&rft.date=2024-01-01&rft.volume=56&rft.issue=1&rft.spage=1&rft.epage=32&rft.pages=1-32&rft.issn=0279-1072&rft.eissn=2159-9777&rft_id=info:doi/10.1080/02791072.2023.2186285&rft_dat=%3Cproquest_cross%3E2942021095%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c370t-f53a81a92e2b79751014106e27266ccb03d01b04fa29def26854ca22ad7fb9823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2942021095&rft_id=info:pmid/36862829&rfr_iscdi=true |